Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-label, Single-dose, Parallel-arm, Phase 1 Study to Investigate the Pharmacokinetic Profile of a Fixed-dose Combination Tablet of Tesofensine and Metoprolol (Tesomet) and Co-administration of Tesofensine Plus Commercial Metoprolol in Adult Healthy Subjects

Next Previous
Search
Trial Profile

A Randomized, Open-label, Single-dose, Parallel-arm, Phase 1 Study to Investigate the Pharmacokinetic Profile of a Fixed-dose Combination Tablet of Tesofensine and Metoprolol (Tesomet) and Co-administration of Tesofensine Plus Commercial Metoprolol in Adult Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 18 May 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Metoprolol/tesofensine (Primary) ; Metoprolol; Tesofensine
  • Indications Prader-Willi syndrome; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Saniona

    • Most Recent Events

    • 29 May 2018 According to a Saniona media release, positive results were announced from this trial.
    • 04 Apr 2018 Status changed to completed.
    • 07 Feb 2018 Acording to a Saniona media release, last participants have had the final visit and the obtained blood samples have been forwarded to a laboratory for analysis.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top